Dan Rose

Medtech Chairman and CEO

[Dan Rose @dorose9]

@theepicmap Trogir

[Dan Rose @dorose9]

@atrupar Vast majority of voting in Switzerland is by mail. Ill informed statement.

[Dan Rose @dorose9]

@monteromiguel @vascularpodcast @hendolat Beautifully expressed. Thanks for sharing, Miguel. You remain an inspiration for continuing the fight.

[Dan Rose @dorose9]

@orange_peelbeef “The sadness accrues.”

[Dan Rose @dorose9]

@monteromiguel @thetoedoctor Awesome result! The future is brighter for many patients.

[Dan Rose @dorose9]

@elonmusk Voting in Switzerland is purely by mail, only signature required.

[Dan Rose @dorose9]

@monteromiguel The word “transcatheter” is important for coding in reimbursement which is why you see the duplicative terminology. The marketing department likely agrees with you.

[ᗰIGᑌEᒪ ᗰOᑎTEᖇO-ᗷᗩKEᖇ @monteromiguel]

An entrepreneurial masterclass! #Limflow @InariMedical @hendolat @VEITHsymposium @VascularSVS @LINCmeeting @vascularpodcast

[Dan Rose @dorose9]

@Jason Val d’Isere/Tignes or St Anton/Lech. Make the decision the week before based on snow conditions and forecast

[Jonathan @Jshortt10]

The @VascularSVS #CPVI exceeded all expectations. Huge thanks to the faculty that made it possible for @CLI_LimFlow to participate 🙌

[Dan Rose @dorose9]

@thetoedoctor @monteromiguel @JillSommerset Congratulations!!!

[Dan Rose @dorose9]

Fantastic discussion on the evolution of Entrepreneurship in the Vascular Space with Dr Peter Schneider, Dr Miguel Montero Baker, and Dr Lucas Ferrer. A super panel who bring a ton of insight and experience to the topic. https://t.co/x387JRpRu9

[LimFlow, Now Part of Stryker @CLI_LimFlow]

4 million+ people have the most severe form of artery disease that blocks blood flow to their feet – Chronic Limb-Threatening Ischemia (#CLTI) – which can lead to #amputation. We are fighting against limb loss. https://t.co/On9OEaWvRx

[LimFlow, Now Part of Stryker @CLI_LimFlow]

Listen to LimFlow CEO Dan Rose discuss the crisis of Chronic Limb-Threatening Ischemia (CLTI) and what FDA approval of the LimFlow System can mean to people who can step off the path to amputation to have their lives and limbs saved.
https://t.co/pT8iqiPMkS
#amputation #limflow

[Market Pathways | MedTech Regulatory & Policy @Market_Pathways]

#ICYMI: @LimFlowUK achieved #FDA clearance. the FDA's decision makes LimFlow the 1st and ONLY FDA-approved #device for transcatheter arterialization of deep veins to treat patients with critical limb ischemia, a long under-served patient population: https://t.co/6LLwBuaNc4

[Dan Rose @dorose9]

@monteromiguel @vascularpodcast @hendolat Amazing group of fine folks!

[LimFlow, Now Part of Stryker @CLI_LimFlow]

Thanks to LINC for a fantastic meeting, and thank you to the TADV focused session presenters (Dr. Peter Schneider, Dr. Miguel Montero Baker, Dr. Roberto Ferraresi, Dr. Steven Kum, Dr Michael Lichtenberg, Dr. Arne Schwindt, Dr. Daniel van den Heuvel, and Dr. Symeon Lechareas)

[Dan Rose @dorose9]

@monteromiguel This work was part of the inspiration for Dr Martin Rothman to co-found LimFlow with Tim Lenihan

[Dan Rose @dorose9]

@DanRose999 Becoming Dan Rose is more of a benefit than a risk, IMHO

[Dan Rose @dorose9]

We are truly blessed to work with great investigators like Dr Dan Clair and Dr Mehdi H. Shishehbor in our mission to improve outcomes for CLTI patients. We are just at the beginning of showing what this technology and procedure can do and the future is ve…https://t.co/r3qHeD0AqI